4: Statement of changes in beneficial ownership of securities-Officer Gallman Cari
4: Statement of changes in beneficial ownership of securities-Director McMullen Michael R.
3/A: Initial statement of beneficial ownership of securities (Amendment)-Director McMullen Michael R.
10-Q: Q2 2024 Earnings Report
8-K: Bristol Myers Squibb Reports Second Quarter Financial Results for 2024
4: Statement of changes in beneficial ownership of securities-Director McMullen Michael R.
3: Initial statement of beneficial ownership of securities-Director McMullen Michael R.
4: Statement of changes in beneficial ownership of securities-Director YALE PHYLLIS R
4: Statement of changes in beneficial ownership of securities-Director Samuels Theodore R. II
4: Statement of changes in beneficial ownership of securities-Director Bhatt Deepak
4: Statement of changes in beneficial ownership of securities-Director Rice Derica W
4: Statement of changes in beneficial ownership of securities-Director Arduini Peter J
11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)
11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)
11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)
8-K: Squibb Appoints Michael R. McMullen to the Company's Board of Directors
8-K: Poll Results of 2024 Annual Meeting of Shareholders
4: Statement of changes in beneficial ownership of securities-Officer Lenkowsky Adam
10-Q: Q1 2024 Earnings Report
8-K: Bristol Myers Squibb Reports First Quarter Financial Results for 2024
No Data